Administration, MetronomicCyclophosphamideAntineoplastic Combined Chemotherapy ProtocolsAngiogenesis InhibitorsAntineoplastic Agents, AlkylatingNeovascularization, PathologicDrug Administration ScheduleXenograft Model Antitumor AssaysMice, SCIDAntineoplastic AgentsChemotherapy, AdjuvantAdministration, OralEndothelial CellsDose-Response Relationship, DrugCombined Modality TherapyCisplatinDoxorubicinTreatment OutcomeNeoadjuvant TherapyDisease-Free SurvivalEtoposideBreast NeoplasmsNeoplasm StagingSurvival AnalysisPrognosisSurvival RateLung NeoplasmsMethotrexateCarboplatinPaclitaxelInduction ChemotherapyVinblastineNeoplasm Recurrence, LocalTaxoidsIfosfamideDrug Resistance, NeoplasmBleomycinNeoplasmsDeoxycytidineOrganoplatinum CompoundsAntimetabolites, AntineoplasticAnthracyclinesChemotherapy, Cancer, Regional PerfusionCytarabineSalvage TherapyCarcinoma, Non-Small-Cell LungFollow-Up StudiesOvarian NeoplasmsNeoplasm MetastasisTesticular NeoplasmsVomitingNeutropeniaTransplantation, AutologousAdenocarcinomaNauseaLymphoma, Non-Hodgkin